Novo Nordisk Us - Search News

Novo Nordisk Expands AI Partnership With Valo Health

Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).

DPA International on MSN · 1d

Novo Nordisk expands drug collaboration with Valo Health

Denmark's Novo Nordisk on Wednesday announced an expansion of its collaboration with Valo Health to discover and develop novel treatments for obesity, type-2 diabetes, and cardiovascular disease. It has committed to a near-term payment of $190 million and the collaboration expects milestone payments of approximately $4.

Business Insider · 2d

Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases

Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to 20 novel drug

Novo Nordisk Stock Rises

Hosted on MSN · 1d

5 Questions Novo Nordisk Must Answer to Drive Its Stock Higher

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of America addresses the company’s earnings and more.

Fintel on MSN · 1d

UBS Upgrades Novo Nordisk A (NVO)

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst Price Forecast Suggests 61.15% Upside As of December 23, 2024, the average one-year price target for Novo Nordisk A is $137.

SchaeffersResearch.com · 1d

Novo Nordisk Stock Jumps on Upgrade to 'Buy'

Novo Nordisk stock has erased 40.7% over the last six months, worsened by a nearly 20% bear gap back in late December following an update on the company's weight loss drug CagriSema. Now "oversold," NVO's 14-day relative strength index (RSI) ranks at 15.

12hon MSN

Trump’s plan to impose tariffs in bid to acquire Greenland could raise prices of Ozempic, Legos

President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to ...

2don MSN

Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50M

Variant Bio is partnering with Novo Nordisk to study metabolic diseases including obesity, using Variant's genomic data from ...

15hon MSN

Trump’s quest for Greenland could make Ozempic even more expensive

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

Ozempic, Lego Bricks and Hearing Aids: What Trump’s Greenland Plan Could Hit

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...

Novo Nordisk: Be Greedy When Others Are Fearful

Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO ...

Novo Nordisk, Valo Health expand drug discovery collaboration

Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, ty ...

1don MSN

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Key Takeaways Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results